Curcumin and endometriosis: Review on potential roles and molecular mechanisms

Biomed Pharmacother. 2018 Jan;97:91-97. doi: 10.1016/j.biopha.2017.10.119. Epub 2017 Nov 6.

Abstract

Endometriosis, an estrogen-dependent inflammatory disease, is one of the most common chronic gynecological disorders affecting women in reproductive age. It is characterized by the presence of endometrial-like tissue outside the uterus. The exact pathophysiology of endometriosis is not still well-known, but the immune system and inflammation have been considered as pivotal factors in disease progression. Turmeric, an important spice all around the world, is obtained from the rhizomes of Curcuma longa, a member of the Zingiberaceae family. It has been used in the prevention and treatment of many diseases since ancient times. Curcumin is the principal polyphenol isolated from turmeric. Several evidences have shown the anti-inflammatory, antioxidant, anti-tumor, anti-angiogenesis, and anti-metastatic activities of curcumin. In this review, relevant articles on the effect of curcumin on endometriosis and possible molecular mechanisms are discussed.

Keywords: Curcumin; Endometriosis; Immune system; Polyphenol; Turmeric.

Publication types

  • Review

MeSH terms

  • Animals
  • Anti-Inflammatory Agents / isolation & purification
  • Anti-Inflammatory Agents / pharmacology
  • Anti-Inflammatory Agents / therapeutic use*
  • Antioxidants / isolation & purification
  • Antioxidants / pharmacology
  • Antioxidants / therapeutic use
  • Curcuma*
  • Curcumin / isolation & purification
  • Curcumin / therapeutic use*
  • Endometriosis / drug therapy*
  • Endometriosis / metabolism
  • Endometriosis / pathology
  • Female
  • Humans
  • Rhizome

Substances

  • Anti-Inflammatory Agents
  • Antioxidants
  • Curcumin